172 related articles for article (PubMed ID: 27431864)
1. General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.
Deng F; Ranta VP; Kidron H; Urtti A
Pharm Res; 2016 Nov; 33(11):2680-90. PubMed ID: 27431864
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic studies on transcorneal permeation of fluorometholone.
Sieg JW; Robinson JR
J Pharm Sci; 1981 Sep; 70(9):1026-9. PubMed ID: 6101147
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmic bioequivalence of steroid/antibiotic combination formulations.
Schoenwald RD; Harris RG; Turner D; Knowles W; Chien DS
Biopharm Drug Dispos; 1987; 8(6):527-48. PubMed ID: 3427210
[TBL] [Abstract][Full Text] [Related]
4. [Ocular pharmacokinetics of pilocarpine micron emulsion in rabbits].
Xu Y; Chen Z; Song J; Zhang J; Xie L
Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):446-8. PubMed ID: 11835858
[TBL] [Abstract][Full Text] [Related]
5. Effect of particle dissolution rate on ocular drug bioavailability.
Hui HW; Robinson JR
J Pharm Sci; 1986 Mar; 75(3):280-7. PubMed ID: 3701612
[TBL] [Abstract][Full Text] [Related]
6. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.
Patton TF; Francoeur M
Am J Ophthalmol; 1978 Feb; 85(2):225-9. PubMed ID: 623195
[TBL] [Abstract][Full Text] [Related]
7. Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine.
Camber O; Edman P
Curr Eye Res; 1989 Jun; 8(6):563-7. PubMed ID: 2743795
[TBL] [Abstract][Full Text] [Related]
8. Theoretical corneal permeation model for ionizable drugs.
Friedrich SW; Cheng YL; Saville BA
J Ocul Pharmacol; 1993; 9(3):229-49. PubMed ID: 8228531
[TBL] [Abstract][Full Text] [Related]
9. The effect of a modified beta-cyclodextrin, SBE4-beta-CD, on the aqueous stability and ocular absorption of pilocarpine.
Järvinen K; Järvinen T; Thompson DO; Stella VJ
Curr Eye Res; 1994 Dec; 13(12):897-905. PubMed ID: 7720398
[TBL] [Abstract][Full Text] [Related]
10. Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine.
Sieg JW; Robinson JR
J Pharm Sci; 1977 Sep; 66(9):1222-8. PubMed ID: 20491
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of topically applied pilocarpine in the albino rabbit eye.
Makoid MC; Robinson JR
J Pharm Sci; 1979 Apr; 68(4):435-43. PubMed ID: 438963
[TBL] [Abstract][Full Text] [Related]
12. Ocular pharmacokinetics and availability of topically applied baicalein in rabbits.
Zhang L; Zhang J; Wang L; Xia H
Curr Eye Res; 2009 Apr; 34(4):257-63. PubMed ID: 19373573
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume.
Patton TF
J Pharm Sci; 1977 Jul; 66(7):1058-9. PubMed ID: 886449
[TBL] [Abstract][Full Text] [Related]
14. The effect of pilocarpine on ocular levobunolol absorption from ophthalmic solutions.
Tang-Liu DD; Richman JB
J Ocul Pharmacol; 1994; 10(4):605-15. PubMed ID: 7714404
[TBL] [Abstract][Full Text] [Related]
15. Corneal absorption of fluorometholone in rabbits. A comparative evaluation of corneal drug transport characteristics in anesthetized and unanesthetized rabbits.
Sieg JW; Robinson JR
Arch Ophthalmol; 1974 Sep; 92(3):240-3. PubMed ID: 4851189
[No Abstract] [Full Text] [Related]
16. [Ocular pharmacokinetics of 0.5% pilocarpine with sodium hyaluronate in rabbits].
Xu Y; Song JZ; Pang GR; Chen ZJ; Zhang JJ; Lü XF
Zhonghua Yan Ke Za Zhi; 2004 Feb; 40(2):87-9. PubMed ID: 15059558
[TBL] [Abstract][Full Text] [Related]
17. Pediatric dosing considerations in ophthalmology--dosage adjustments based on aqueous humor volume ratio.
Patton TF
J Pediatr Ophthalmol; 1977; 14(4):254-6. PubMed ID: 894449
[TBL] [Abstract][Full Text] [Related]
18. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
Patel N; Nakrani H; Raval M; Sheth N
Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
[TBL] [Abstract][Full Text] [Related]
19. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
[TBL] [Abstract][Full Text] [Related]
20. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
